BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 455578)

  • 1. Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea.
    McConnell WR; Kari P; Hill DL
    Cancer Chemother Pharmacol; 1979; 2(3):221-3. PubMed ID: 455578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on the levels of glutathione and lipid peroxidation and the activity of glutathione reductase in liver and lung.
    Nakagawa Y
    Toxicol Lett; 1987 Feb; 35(2-3):269-75. PubMed ID: 3824416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells.
    Gorbacheva LB; Kukushkina GV; Durdeva AD; Ponomarenko NA
    Neoplasma; 1988; 35(1):3-14. PubMed ID: 3127736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
    Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivo.
    Ribrag V; Massaad L; Janot F; Bissery MC; Parise O; Gouyette A; Chabot GG
    Leuk Res; 1994 Nov; 18(11):829-35. PubMed ID: 7967709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of N-nitrosourea-induced changes in the nucleoid structure and activity of repair enzymes in the development of drug resistance in mice with leukemia L1210].
    Durdyeva ED; Ponomarenko NA; Kukushkina GV; Gorbacheva LB
    Biokhimiia; 1987 Aug; 52(8):1335-43. PubMed ID: 3663767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione and N-acetylcysteine conjugates of 2-chloroethyl isocyanate. Identification as metabolites of N,N'-bis(2-chloroethyl)-N-nitrosourea in the rat and inhibitory properties toward glutathione reductase in vitro.
    Davis MR; Kassahun K; Jochheim CM; Brandt KM; Baillie TA
    Chem Res Toxicol; 1993; 6(3):376-83. PubMed ID: 8318660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue.
    Maker HS; Weiss C; Brannan TS
    Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):355-66. PubMed ID: 6622814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function.
    Vanhoefer U; Yin MB; Harstrick A; Seeber S; Rustum YM
    Biochem Pharmacol; 1997 Mar; 53(6):801-9. PubMed ID: 9113101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of BCNU (carmustine) on tissue glutathione reductase activity.
    Kehrer JP
    Toxicol Lett; 1983 Jun; 17(1-2):63-8. PubMed ID: 6623510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell cystine uptake and glutathione increase with N,N-bis(2-chloroethyl)-N-nitrosourea exposure.
    Deneke SM; Lawrence RA; Jenkinson SG
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L301-4. PubMed ID: 1550253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Cohen MB; Duvel DL
    Biochem Pharmacol; 1988 Sep; 37(17):3317-20. PubMed ID: 3401259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione.
    Ali-Osman F; Caughlan J; Gray GS
    Cancer Res; 1989 Nov; 49(21):5954-8. PubMed ID: 2551496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
    Rice KP; Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe depletion of cellular thiols and glutathione-related enzymes of a carmustine-resistant L1210 strain associates with collateral sensitivity to cyclophosphamide.
    Institoris E; Tretter L; Gaál D
    Cancer Chemother Pharmacol; 1993; 33(1):85-8. PubMed ID: 8269595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between the changes in the structure and synthesis of DNA in the cells of mouse leukemia L1210 induced by 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea].
    Durdyeva ED; Kukushkina GV; Gorbacheva KB
    Biull Eksp Biol Med; 1986 Feb; 101(2):192-5. PubMed ID: 3947737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and doxorubicin on the cardiac and hepatic glutathione systems.
    Paraidathathu T; Combs AB; Kehrer JP
    Toxicology; 1985 May; 35(2):113-24. PubMed ID: 4002239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
    Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
    J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
    August EM; Prusoff WH
    Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.